ロード中...
Knockdown of arsenic resistance protein 2 inhibits human glioblastoma cell proliferation through the MAPK/ERK pathway
It is generally known that glioblastoma is the most common primary malignant brain tumor and that it is highly aggressive and deadly. Although surgical and pharmacological therapies have made long-term progress, glioblastoma remains extremely lethal and has an uncommonly low survival rate. Therefore...
保存先:
| 出版年: | Oncol Rep |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6196630/ https://ncbi.nlm.nih.gov/pubmed/30542699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6777 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|